Additionally, Yokoyama et al[15] found a correlation between high initial white blood cell count and increased nm23-H2 mRNA levels in CML patients, suggesting that white blood cell count is an important biomarker of disease progression. This evidence concerns the gene NME2 and chronic myelogenous leukemia, BCR-ABL1 positive.